Evidence map›Paper›PMID 33981469›Full record

ReviewKidney international supplements2021

International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America.

Marina Wainstein, Aminu K Bello, Vivekanand Jha, David C H Harris, Adeera Levin, Maria C Gonzalez-Bedat, Guillermo J Rosa-Diez, Alejandro Ferreiro Fuentes, Laura Sola, Roberto Pecoits-Filho and 14 more

Abstract readReview
In one paragraph

Review in Kidney international supplements, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. [Peritoneal dialysis impact on quality of life in elderly].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Marina WainsteinNational Health and Medical Research Council Chronic Kidney Disease Centre of Research Excellence and Chronic Kidney Disease in Queensland, University of Queensland, Brisbane, Queensland, Australia.
Aminu K BelloDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Vivekanand JhaGeorge Institute for Global Health, University of New South Wales, New Delhi, India.
David C H HarrisCentre for Transplantation and Renal Research, The Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Maria C Gonzalez-BedatExecutive Board of the Latin American Dialysis and Transplantation Registry, Montevideo, Uruguay.
Guillermo J Rosa-DiezDivision of Nephrology, Department of Medicine, University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Alejandro Ferreiro FuentesCentro de Nefrología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Laura SolaDialysis Unit, Centro Asistencial del Sindicato Médico del Uruguay Institución de Asistencia Médica Privada de Profesionales Sin Fines de Lucro, Montevideo, Uruguay.
Roberto Pecoits-FilhoSchool of Medicine, Pontificia Universidade Catolica do Paraná, Curitiba, Brazil.
Rolando Claure-Del GranadoDivision of Nephrology, Department of Medicine, Hospital Obrero #2-Caja Nacional de Salud, Universidad Mayor de San Simon School of Medicine, Cochabamba, Bolivia.
Magdalena MaderoDivision of Nephrology, Department of Medicine, National Heart Institute, Mexico City, Mexico.
Mohamed A OsmanDepartment of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Syed SaadDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Deenaz ZaidiDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Meaghan LunneyDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Feng YeDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Ivor J KatzDivision of Medicine, Department of Renal Medicine, St George and Sutherland Hospitals, University of New South Wales, Sydney, New South Wales, Australia.
Maryam KhanFaculty of Science, University of Alberta, Edmonton, Alberta, Canada.
Sally ShrapnelSchool of Mathematics and Physics, University of Queensland, Brisbane, Queensland, Australia.
Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ikechi G OkpechiDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
David W JohnsonDepartment of Nephrology, Metro South and Ipswich Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
ISN Latin America Regional Board

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Latin America is a region with a widely variable socioeconomic landscape, facing a surge in noncommunicable diseases, including chronic kidney disease and kidney failure, exposing significant limitations in the delivery of care. Despite region-wide efforts to explore and address these limitations, much uncertainty remains as to the capacity, accessibility, and quality of kidney failure care in Latin America. Through this second iteration of the International Society of Nephrology Global Kidney Health Atlas, we aimed to report on these indicators to provide a comprehensive map of kidney failure care in the region. Survey responses were received from 18 (64.2%) countries, representing 93.8% of the total population in Latin America. The median prevalence and incidence of treated kidney failure in Latin America were 715 and 157 per million population, respectively, the latter being higher than the global median (142 per million population), with Puerto Rico, Mexico, and El Salvador experiencing much of this growing burden. In most countries, public and private systems collectively funded most aspects of kidney replacement therapy (dialysis and transplantation) care, with patients incurring at least 1% to 25% of out-of-pocket costs. In most countries, >90% of dialysis patients able to access kidney replacement therapy received hemodialysis (n = 11; 5 high income and 6 upper-middle income), and only a small minority began with peritoneal dialysis (1%-10% in 67% of countries; n = 12). Few countries had chronic kidney disease registries or targeted detection programs. There is a large variability in the availability, accessibility, and quality of kidney failure care in Latin America, which appears to be subject to individual countries' funding structures, underreliance on cheap kidney replacement therapy, such as peritoneal dialysis, and limited chronic kidney disease surveillance and management initiatives.

Indexed as

chronic kidney diseasedialysisend-stage kidney diseasekidney failurekidney registrieskidney transplantation

Identifiers

PMID33981469
PMCPMC8084731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.